Selected research
Market Structure
Global Bacterial Serotyping - Antisera Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Bacterial Serotyping - Antisera market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Bacterial Serotyping - Antisera is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Bacterial Serotyping - Antisera is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bacterial Serotyping - Antisera is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Bacterial Serotyping - Antisera is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Bacterial Serotyping - Antisera include Arlington Scientific, BioMérieux, Bio-Rad, Biotec, Cardinal Health, Gold Standard Diagnostics, Hardy Diagnostics, Mast Group and Microgen Bioproducts, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Bacterial Serotyping - Antisera market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Bacterial Serotyping - Antisera and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Bacterial Serotyping - Antisera sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bacterial Serotyping - Antisera market size, projected growth trends, production technologies, key applications, and end-use industries.
Bacterial Serotyping - Antisera Segment by Company
Arlington Scientific
BioMérieux
Bio-Rad
Biotec
Cardinal Health
Gold Standard Diagnostics
Hardy Diagnostics
Mast Group
Microgen Bioproducts
Pro Lab Diagnostics
Thermo Fisher
Bacterial Serotyping - Antisera Segment by Type
Shigella
Yersinia
Pseudomonas Aeruginosa
Salmonella
Enterobacter
Bacterial Serotyping - Antisera Segment by Application
Food and Industrial Microbiology
Clinical Diagnosis
Others
Bacterial Serotyping - Antisera Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bacterial Serotyping - Antisera market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bacterial Serotyping - Antisera and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bacterial Serotyping - Antisera.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Bacterial Serotyping - Antisera market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bacterial Serotyping - Antisera manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bacterial Serotyping - Antisera in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Bacterial Serotyping - Antisera in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Shigella
- Yersinia
- Pseudomonas Aeruginosa
- Salmonella
- Enterobacter
Applications
- Food and Industrial Microbiology
- Clinical Diagnosis
- Others
Companies covered
- Arlington Scientific
- BioMérieux
- Bio-Rad
- Biotec
- Cardinal Health
- Gold Standard Diagnostics
- Hardy Diagnostics
- Mast Group
- Microgen Bioproducts
- Pro Lab Diagnostics
- Thermo Fisher
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Bacterial Serotyping - Antisera Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Bacterial Serotyping - Antisera Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Bacterial Serotyping - Antisera Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Bacterial Serotyping - Antisera Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Bacterial Serotyping - Antisera Market Dynamics
- 2.1 Bacterial Serotyping - Antisera Industry Trends
- 2.2 Bacterial Serotyping - Antisera Industry Drivers
- 2.3 Bacterial Serotyping - Antisera Industry Opportunities and Challenges
- 2.4 Bacterial Serotyping - Antisera Industry Restraints
3 Bacterial Serotyping - Antisera Market by Manufacturers
- 3.1 Global Bacterial Serotyping - Antisera Revenue by Manufacturers (2021-2026)
- 3.2 Global Bacterial Serotyping - Antisera Sales by Manufacturers (2021-2026)
- 3.3 Global Bacterial Serotyping - Antisera Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Bacterial Serotyping - Antisera Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Bacterial Serotyping - Antisera Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Bacterial Serotyping - Antisera Manufacturers, Product Type & Application
- 3.7 Global Bacterial Serotyping - Antisera Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Bacterial Serotyping - Antisera Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Bacterial Serotyping - Antisera Players Market Share by Revenue in 2025
- 3.8.3 2025 Bacterial Serotyping - Antisera Tier 1, Tier 2, and Tier 3
4 Bacterial Serotyping - Antisera Market by Type
- 4.1 Bacterial Serotyping - Antisera Type Introduction
- 4.1.1 Shigella
- 4.1.2 Yersinia
- 4.1.3 Pseudomonas Aeruginosa
- 4.1.4 Salmonella
- 4.1.5 Enterobacter
- 4.2 Global Bacterial Serotyping - Antisera Sales by Type
- 4.2.1 Global Bacterial Serotyping - Antisera Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Bacterial Serotyping - Antisera Sales by Type (2021-2032)
- 4.2.3 Global Bacterial Serotyping - Antisera Sales Market Share by Type (2021-2032)
- 4.3 Global Bacterial Serotyping - Antisera Revenue by Type
- 4.3.1 Global Bacterial Serotyping - Antisera Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Bacterial Serotyping - Antisera Revenue by Type (2021-2032)
- 4.3.3 Global Bacterial Serotyping - Antisera Revenue Market Share by Type (2021-2032)
5 Bacterial Serotyping - Antisera Market by Application
- 5.1 Bacterial Serotyping - Antisera Application Introduction
- 5.1.1 Food and Industrial Microbiology
- 5.1.2 Clinical Diagnosis
- 5.1.3 Others
- 5.2 Global Bacterial Serotyping - Antisera Sales by Application
- 5.2.1 Global Bacterial Serotyping - Antisera Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Bacterial Serotyping - Antisera Sales by Application (2021-2032)
- 5.2.3 Global Bacterial Serotyping - Antisera Sales Market Share by Application (2021-2032)
- 5.3 Global Bacterial Serotyping - Antisera Revenue by Application
- 5.3.1 Global Bacterial Serotyping - Antisera Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Bacterial Serotyping - Antisera Revenue by Application (2021-2032)
- 5.3.3 Global Bacterial Serotyping - Antisera Revenue Market Share by Application (2021-2032)
6 Global Bacterial Serotyping - Antisera Sales by Region
- 6.1 Global Bacterial Serotyping - Antisera Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Bacterial Serotyping - Antisera Sales by Region (2021-2032)
- 6.2.1 Global Bacterial Serotyping - Antisera Sales by Region (2021-2026)
- 6.2.2 Global Bacterial Serotyping - Antisera Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Bacterial Serotyping - Antisera Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Bacterial Serotyping - Antisera Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Bacterial Serotyping - Antisera Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Bacterial Serotyping - Antisera Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Bacterial Serotyping - Antisera Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Bacterial Serotyping - Antisera Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Bacterial Serotyping - Antisera Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Bacterial Serotyping - Antisera Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Bacterial Serotyping - Antisera Revenue by Region
- 7.1 Global Bacterial Serotyping - Antisera Revenue by Region
- 7.1.1 Global Bacterial Serotyping - Antisera Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Bacterial Serotyping - Antisera Revenue by Region (2021-2026)
- 7.1.3 Global Bacterial Serotyping - Antisera Revenue by Region (2027-2032)
- 7.1.4 Global Bacterial Serotyping - Antisera Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Bacterial Serotyping - Antisera Revenue (2021-2032)
- 7.2.2 North America Bacterial Serotyping - Antisera Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Bacterial Serotyping - Antisera Revenue (2021-2032)
- 7.3.2 Europe Bacterial Serotyping - Antisera Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Bacterial Serotyping - Antisera Revenue (2021-2032)
- 7.4.2 Asia-Pacific Bacterial Serotyping - Antisera Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Bacterial Serotyping - Antisera Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Bacterial Serotyping - Antisera Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Arlington Scientific
- 8.1.1 Arlington Scientific Company Information
- 8.1.2 Arlington Scientific Business Overview
- 8.1.3 Arlington Scientific Bacterial Serotyping - Antisera Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Arlington Scientific Bacterial Serotyping - Antisera Product Portfolio
- 8.1.5 Arlington Scientific Recent Developments
- 8.2 BioMérieux
- 8.2.1 BioMérieux Company Information
- 8.2.2 BioMérieux Business Overview
- 8.2.3 BioMérieux Bacterial Serotyping - Antisera Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 BioMérieux Bacterial Serotyping - Antisera Product Portfolio
- 8.2.5 BioMérieux Recent Developments
- 8.3 Bio-Rad
- 8.3.1 Bio-Rad Company Information
- 8.3.2 Bio-Rad Business Overview
- 8.3.3 Bio-Rad Bacterial Serotyping - Antisera Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Bio-Rad Bacterial Serotyping - Antisera Product Portfolio
- 8.3.5 Bio-Rad Recent Developments
- 8.4 Biotec
- 8.4.1 Biotec Company Information
- 8.4.2 Biotec Business Overview
- 8.4.3 Biotec Bacterial Serotyping - Antisera Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Biotec Bacterial Serotyping - Antisera Product Portfolio
- 8.4.5 Biotec Recent Developments
- 8.5 Cardinal Health
- 8.5.1 Cardinal Health Company Information
- 8.5.2 Cardinal Health Business Overview
- 8.5.3 Cardinal Health Bacterial Serotyping - Antisera Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Cardinal Health Bacterial Serotyping - Antisera Product Portfolio
- 8.5.5 Cardinal Health Recent Developments
- 8.6 Gold Standard Diagnostics
- 8.6.1 Gold Standard Diagnostics Company Information
- 8.6.2 Gold Standard Diagnostics Business Overview
- 8.6.3 Gold Standard Diagnostics Bacterial Serotyping - Antisera Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Gold Standard Diagnostics Bacterial Serotyping - Antisera Product Portfolio
- 8.6.5 Gold Standard Diagnostics Recent Developments
- 8.7 Hardy Diagnostics
- 8.7.1 Hardy Diagnostics Company Information
- 8.7.2 Hardy Diagnostics Business Overview
- 8.7.3 Hardy Diagnostics Bacterial Serotyping - Antisera Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Hardy Diagnostics Bacterial Serotyping - Antisera Product Portfolio
- 8.7.5 Hardy Diagnostics Recent Developments
- 8.8 Mast Group
- 8.8.1 Mast Group Company Information
- 8.8.2 Mast Group Business Overview
- 8.8.3 Mast Group Bacterial Serotyping - Antisera Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Mast Group Bacterial Serotyping - Antisera Product Portfolio
- 8.8.5 Mast Group Recent Developments
- 8.9 Microgen Bioproducts
- 8.9.1 Microgen Bioproducts Company Information
- 8.9.2 Microgen Bioproducts Business Overview
- 8.9.3 Microgen Bioproducts Bacterial Serotyping - Antisera Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Microgen Bioproducts Bacterial Serotyping - Antisera Product Portfolio
- 8.9.5 Microgen Bioproducts Recent Developments
- 8.10 Pro Lab Diagnostics
- 8.10.1 Pro Lab Diagnostics Company Information
- 8.10.2 Pro Lab Diagnostics Business Overview
- 8.10.3 Pro Lab Diagnostics Bacterial Serotyping - Antisera Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Pro Lab Diagnostics Bacterial Serotyping - Antisera Product Portfolio
- 8.10.5 Pro Lab Diagnostics Recent Developments
- 8.11 Thermo Fisher
- 8.11.1 Thermo Fisher Company Information
- 8.11.2 Thermo Fisher Business Overview
- 8.11.3 Thermo Fisher Bacterial Serotyping - Antisera Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Thermo Fisher Bacterial Serotyping - Antisera Product Portfolio
- 8.11.5 Thermo Fisher Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Bacterial Serotyping - Antisera Value Chain Analysis
- 9.1.1 Bacterial Serotyping - Antisera Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Bacterial Serotyping - Antisera Production Mode & Process
- 9.2 Bacterial Serotyping - Antisera Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Bacterial Serotyping - Antisera Distributors
- 9.2.3 Bacterial Serotyping - Antisera Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst